Avidity Biosciences
RNA
#1835
Rank
HK$83.98 B
Marketcap
HK$557.41
Share price
0.13%
Change (1 day)
94.23%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: HK$83.98 Billion

As of December 2025 Avidity Biosciences has a market cap of HK$83.98 Billion. This makes Avidity Biosciences the world's 1835th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$83.98 B201.14%
2024HK$27.88 B398.36%
2023HK$5.59 B-51.43%
2022HK$11.52 B32.57%
2021HK$8.69 B17.08%
2020HK$7.42 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Avidity Biosciences was reported to be:

HK$83.98 Billion
by Nasdaq info icon info icon
HK$83.98 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
HK$48.26 B-42.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.38 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$18.15 B-78.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$22.50 B-73.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$0.96 B-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
HK$85.06 B 1.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.151 T 1,271.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$760.42 B 805.40%๐Ÿ‡ฌ๐Ÿ‡ง UK